PODD 2025 presentation will spotlight SnapShot's ability to deliver ultra-high concentration doses of mAbs and biologics via standard subcutaneous ...
Nolato AB ( ($SE:NOLA.B) ) just unveiled an update. Nolato AB announced it will release its interim report for the third quarter of 2025 on ...
VLTR-559 was well tolerated at target clinical dose with a safety profile similar to approved short-acting anti-VEGF therapies for wet AMD Data featured in an oral presentation at the at the ...
Baystreet.ca News Commentary – Longevity science advances reveal how genes from supercentenarians can reverse cardiac aging[1 ...
(RTi); David Barry, associate director for PE, PP and PS for PetroChemWire (PCW) by OPIS; Michael Greenberg, CEO of Resintel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback